Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Stephens & Co. Downgrades NeoGenomics to Equal-Weight, Lowers Price Target to $16

Stephens & Co. downgrades NeoGenomics (NASDAQ:NEO) from Overweight to Equal-Weight and lowers the price target from $34 to $16.
byBenzinga Newsdesk
March 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Stephens & Co. downgrades NeoGenomics (NASDAQ:NEO) from Overweight to Equal-Weight and lowers the price target from $34 to $16.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0